Streetbeat News

Products Services

BLRX

BioLineRx is set to present a poster on the economic model data for APHEXDA at the ISPOR 2024 conference today. This presentation could highlight the potential economic benefits and cost-effectiveness of APHEXDA, possibly influencing investor perception and the valuation of BioLineRx.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:03 am

EYPT

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) announced topline results from its Phase 2 PAVIA trial of DURAVYU (vorolanib intravitreal insert) for non-proliferative diabetic retinopathy (NPDR). The trial showed a biologic effect with a favorable safety profile but did not meet its primary endpoint. The company will review the full 12-month data to decide on DURAVYU's future in NPDR treatment.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:03 am

RDHL

RedHill Biopharma Ltd. announced the issuance of a new Chinese patent for opaganib as a therapy for inhibiting single-stranded RNA virus replication, notably Ebola, valid through 2035. The patent was issued by the Chinese National Intellectual Property Administration.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:02 am

BMY

The FDA has accepted Bristol Myers Squibb's application for a subcutaneous form of Nivolumab, combined with Hyaluronidase, setting a Prescription Drug User Fee Act goal date of February 28, 2025.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:01 am

XERS

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) has entered into an exclusive worldwide collaboration and license agreement with Beta Bionics, Inc. for the development and commercialization of a glucagon product using Xeris' XeriSol technology for Beta Bionics' bi-hormonal pump systems.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:01 am

GM

GS

UBS

General Motors Co (NYSE:GM) backed Chinese self-driving company Beijing Momenta Technology Co. has confidentially filed for a U.S. IPO, aiming to raise $200-$300 million. The IPO is being managed by China International Capital Corp., Goldman Sachs Group Inc. (NYSE:GS), and UBS Group AG (NYSE:UBS), with a potential launch this year. The decision to proceed with the U.S. IPO is still under consideration. GM's shares rose 0.53% in premarket trading.

Portfolio Pulse from Shivani Kumaresan

May 06, 2024 | 10:46 am

ONDS

Ondas Holdings Inc. has received an initial purchase order for its Iron-Drone Raider C-UAS from an Israeli defense company, following a testing and integration process. This order is expected to lead to further orders from this and other customers.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 10:36 am

LILM

Lilium N.V. (NASDAQ:LILM), an eVTOL jet developer, announced a partnership with UrbanLink to operate Lilium Jets in South Florida. UrbanLink will purchase 20 Lilium Jets, marking the first U.S. airline commitment to eVTOL integration. Financial terms were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 10:32 am

LKNCY

SBUX

VTI

XLY

Former Starbucks CEO Howard Schultz has called for a major overhaul of the company amid a sales slump, citing a need to revamp operations and improve the customer experience. Starbucks faces challenges from inflation, competition in China from Luckin Coffee, and a significant drop in sales due to various factors. The company's second-quarter results fell short of expectations, with a 4% decline in global comparable store sales and earnings missing analyst estimates. Despite these challenges, Schultz remains optimistic about Starbucks' recovery, especially in China. Starbucks stock has declined over 31% in the last 12 months, but shares are trading higher in premarket.

Portfolio Pulse from Shivani Kumaresan

May 06, 2024 | 10:31 am

GENE

Genetic Technologies Limited (GTG) has signed a strategic joint sales & marketing agreement with Wellworks for You Inc., aiming to incorporate GTG's geneType portfolio of tests into Wellworks' employee wellness solutions. This deal covers 750 employer groups and provides access to over 2 million U.S. employees.

Portfolio Pulse from Charles Gross

May 06, 2024 | 10:18 am